The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer.
Helena Margaret Earl
Honoraria - Advisory Boards
Research Funding - Roche
C Blenkinsop
No relevant relationships to disclose
L Grybowicz
No relevant relationships to disclose
A-L Vallier
No relevant relationships to disclose
David A. Cameron
Honoraria - Advisory Boards
John M.S. Bartlett
Honoraria - Advisory Boards
Nicholas Murray
Honoraria - Advisory Boards
Carlos Caldas
Honoraria - Advisory Boards
J Thomas
Honoraria - Advisory Boards
Janet A Dunn
Honoraria - Advisory Boards
Helen B Higgins
No relevant relationships to disclose
Louise Hiller
No relevant relationships to disclose
Larry Hayward
Honoraria - Advisory Boards